Already a member? Sign in
Category: Supplements
See also: Ginkgo Biloba Extract, Ginkgo Biloba with Vinpocetine, Ginkgold, Ginkoba, Ginseng Siberian with Ginkgo Biloba
Ginkgo biloba is a natural herb. Most uses of ginkgo have centered on improvement in regional (ie, CNS) or peripheral blood flow and oxygen delivery. Also known as Eun-haeng; Fossil Tree; Kew Tree; Silver Apricot.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| General health | 51 | 5 |
|
|
|||
| Memory problems | 37 | 10 |
|
|
|
|
|
| Brain fog | 33 | 10 |
|
|
|
|
|
| Cognitive impairment | 12 | 4 |
|
|
|
||
| Other | 10 | 2 |
|
|
|||
| MS (Multiple Sclerosis) | 10 | 4 |
|
|
See all 143 patients currently taking Ginkgo Biloba
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Ginkgo Biloba
| Elevated blood pressure | 1 | |
|---|---|---|
| Thin nails (ie bendable or easily tearable) | 1 |
Frequently reported dosages based on patients currently taking Ginkgo Biloba. See all 24 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Did not seem to work | 27 | ||
| Other | 19 | ||
| Personal research | 10 | ||
| Not indicated | 5 | ||
| Expense | 5 | ||
| Side effects too severe | 3 | ||
| Course of treatment ended | 3 | ||
| Doctor's advice | 2 |
Adherence
Taking treatment as prescribed
Adherence of Ginkgo Biloba
Always |
23 | 66% |
|
|---|---|---|---|
Usually |
8 | 23% |
|
Sometimes |
2 | 6% |
|
Never |
2 | 6% |
|
Burden
Difficulty being on treatment
Burden of Ginkgo Biloba
Very |
0 | 0% |
|
|---|---|---|---|
Somewhat |
5 | 14% |
|
A little |
1 | 3% |
|
Not at all |
29 | 83% |
|
Cost
Paid out of pocket
Cost of Ginkgo Biloba
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
0 | 0% |
|
$25-49 |
0 | 0% |
|
< $25 |
19 | 100% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on February 11, 2012.